Shanghai Kehua Bio-engineering: Announcement of interest payment for convertible bonds of the company due in 2024.
Shanghai Kehua Bio-engineering: Announcement regarding non-adjustment of the conversion price for "Ke Hua Convertible Bonds".
Shanghai Kehua Bio-engineering: Announcement of Triggering of Downward Revision Condition for Convertible Bond Conversion Price of Kehua Bond
Shanghai Kehua Bio-engineering: Announcement regarding the debt-for-equity swaps in the second quarter of 2024 for convertible bonds.
Shanghai Kehua Bio-engineering: Announcement on Providing Share Pledge Guarantees for the Repurchase of Shares by a Wholly-owned Subsidiary of the Company for its Controlled Subsidiaries.
Shanghai Kehua Bio-engineering: Shanghai Kehua Bio-Engineering Co., Ltd. Publicly Issued Convertible Corporate Bonds 2024 Tracking Rating Report
Kehua Biotech: Legal Opinion of Beijing Jindu (Guangzhou) Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Kehua Bioengineering Co., Ltd.
Kehua Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Kehua Biotech: Announcement on convertible debt-for-equity swaps in the first quarter of 2024
Kehua Biotech: Joint Credit Assessment Co., Ltd. Notice on matters such as the change in control of Shanghai Kehua Bioengineering Co., Ltd. and the completion of early election of the board of directors and supervisors
Kehua Biotech: Announcement on the launch of foreign exchange hedging business by the company and its subsidiaries
Kehua Biotech: Report of the Audit Committee of the Board of Directors on evaluating the performance of accounting firms in 2023 and carrying out supervisory duties
Kehua Biotech: Announcement on preparation for asset impairment in 2023
Kehua Biotech: Announcement on the use of own funds by the company and its subsidiaries for cash management
Kehua Biotech: Internal Control Self-Assessment Report
Kehua Biotech: Notice of Annual General Meeting of Shareholders
Kehua Biotech: Announcement on the change in control
Kehua Biotech: Legal Opinion of Beijing Jindu (Guangzhou) Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Kehua Biotech Co., Ltd.
Kehua Biotech: Announcement on the completion of early election of the board of directors and the board of supervisors and the appointment of senior management, securities affairs representatives, and heads of the audit department
Kehua Biotech: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
No Data